Phibro Animal Health | PAHC - Ebitda

Stock Price
52.26
Daily Change
0.99 1.93%
Monthly
31.08%
Yearly
102.79%
Q1 Forecast
12.72

Phibro Animal Health reported $30.48M in EBITDA for its fiscal quarter ending in September of 2024.





Ebitda Change Date
Align Technology USD 183.84M 19.77M Sep/2025
ANI Pharmaceuticals USD 59.6M 5.52M Sep/2025
Aurora Cannabis CAD 15.37M 26.8M Sep/2025
Bristol-Myers Squibb USD 4.24B 967M Sep/2025
Canopy Growth CAD 16.62M 38.45M Sep/2025
Corcept Therapeutics USD 27.14M 23.27M Jun/2025
Eli Lilly USD 7.88B 378.1M Sep/2025
Henry Schein USD 295M 39M Sep/2025
Idexx Laboratories USD 391.47M 17.97M Sep/2025
Knight Therapeutics CAD 15.51M 3.39M Jun/2025
Merck USD 8.39B 1.97B Sep/2025
Nektar Therapeutics USD -31.81M 70K Sep/2023
Pacira USD 49.36M 4.96M Sep/2025
Phibro Animal Health USD 30.48M 1.1M Sep/2024
Prestige Brands USD 90.82M 3.99M Dec/2025
Supernus Pharmaceuticals USD 41.9M 432K Sep/2025
Zoetis USD 1.04B 87M Sep/2025